Biomedicine
Aporo Biomedical Announces Global Licensing Agreement for Proprietary Polymers Used to Treat Structural Heart Disease
Published in Cardiovascular Business Week, February 12th, 2008
Aporo Biomedical, a San Francisco/Bay Area-based medical device company, reported an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP(TM)). Aporo's goal is to provide significant clinical value by delivering novel transcatheter devices that close defects and then biodegrade over time, leaving behind no permanent implant. Initially, Aporo will use these materials to treat Patent Foramen Ovale (PFO), a type of structural heart disease that involves closing an open tunnel between the upper left and right chambers of the heart. In the future, the company will use the polymers in devices to treat Atrial Septal Defect...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Angioplasty
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc. - Anti-Infectives
Acorda Therapeutics Announces Successful Thorough QT Study of Fampridine-SR - Ascent Healthcare Solutions
Premier Extends Partnership with Ascent Healthcare Solutions for Medical Device Reprocessing - Atherosclerosis
New findings from Wyeth in the area of atherosclerosis described - Atherotech, Inc.
Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy - Biomedicine
mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
